IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,521 | +10.6% | 739 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $30,321 | +15.1% | 739 | +0.3% | 0.01% | 0.0% |
| Q1 2023 | $26,340 | -4.9% | 737 | +0.5% | 0.01% | 0.0% |
| Q4 2022 | $27,685 | -16.1% | 733 | -0.8% | 0.01% | -28.6% |
| Q3 2022 | $33,000 | +22.2% | 739 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $27,000 | -10.0% | 739 | -10.1% | 0.01% | +20.0% |
| Q1 2022 | $30,000 | +130.8% | 822 | +94.3% | 0.01% | +150.0% |
| Q4 2021 | $13,000 | -13.3% | 423 | -3.6% | 0.00% | -33.3% |
| Q3 2021 | $15,000 | +200.0% | 439 | +262.8% | 0.00% | +200.0% |
| Q2 2021 | $5,000 | -28.6% | 121 | -18.2% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -56.2% | 148 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $16,000 | +45.5% | 296 | +23.8% | 0.00% | -33.3% |
| Q3 2020 | $11,000 | 0.0% | 239 | +22.6% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +83.3% | 195 | +57.3% | 0.00% | +50.0% |
| Q1 2020 | $6,000 | -50.0% | 124 | -39.5% | 0.00% | -60.0% |
| Q4 2019 | $12,000 | 0.0% | 205 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $12,000 | -7.7% | 205 | +1.0% | 0.01% | 0.0% |
| Q2 2019 | $13,000 | -18.8% | 203 | +1.5% | 0.01% | -28.6% |
| Q1 2019 | $16,000 | +220.0% | 200 | +100.0% | 0.01% | +133.3% |
| Q4 2018 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | -71.4% | 100 | -65.0% | 0.00% | -70.0% |
| Q4 2016 | $14,000 | +250.0% | 286 | +186.0% | 0.01% | +233.3% |
| Q3 2016 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,000 | -50.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -33.3% | 100 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $6,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |